XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Series E Preferred Stock
Series E Preferred Stock
Preferred Stock
Series E Preferred Stock
Additional Paid-in Capital
Common Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Beginning balance at Dec. 31, 2018 $ (36,525) $ 0 $ 74 $ 546,230 $ (4,877) $ (577,817) $ (135)            
Beginning Balance (shares) at Dec. 31, 2018   0 73,980,000                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) (18,190)         (18,264) 74            
Foreign currency translation adjustment 1,207       1,207                
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 916   $ 1 915                  
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)     737,000                    
Taxes withheld on net settled vesting of restricted stock units (318)     (318)                  
Issuance of shares 241   $ 0 241                  
Issuance of shares (shares)     46,000                    
Exercise of warrants 10,639   $ 4 10,635                  
Exercise of warrants (shares)     4,222,000                    
Share-based compensation 4,702     4,702                  
Ending balance at Jun. 30, 2019 (37,328) $ 0 $ 79 562,405 (3,670) (596,081) (61)            
Ending Balance (shares) at Jun. 30, 2019   0 78,985,000                    
Beginning balance at Mar. 31, 2019 (32,596) $ 0 $ 79 558,208 (5,460) (585,302) (121)            
Beginning Balance (shares) at Mar. 31, 2019   0 78,699,000                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) (10,719)         (10,779) 60            
Foreign currency translation adjustment 1,790       1,790                
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 517   $ 0 517                  
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)     240,000                    
Taxes withheld on net settled vesting of restricted stock units (206)     (206)                  
Issuance of shares                     $ 241 $ 0 $ 241
Issuance of shares (shares)                       46,000  
Share-based compensation 3,645     3,645                  
Ending balance at Jun. 30, 2019 (37,328) $ 0 $ 79 562,405 (3,670) (596,081) (61)            
Ending Balance (shares) at Jun. 30, 2019   0 78,985,000                    
Beginning balance at Dec. 31, 2019 (37,358) $ 0 $ 82 584,862 (3,879) (618,303) (120)            
Beginning Balance (shares) at Dec. 31, 2019   10,000 81,974,000                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) (93,002)         (93,028) 26            
Foreign currency translation adjustment (11,904)       (11,904)                
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 1,712   $ 1 1,711                  
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)     967,000                    
Taxes withheld on net settled vesting of restricted stock units (281)     (281)                  
Issuance of shares               $ 25,000   $ 25,000      
Issuance of shares (shares)                 25,000        
Issuance of Series E preferred stock in lieu of interest (shares)                 2,000        
Issuance of Series E preferred stock in lieu of interest               $ 2,330   $ 2,330      
Repurchase of Series E preferred stock (2,354)     (2,354)                  
Repurchase of Series E preferred stock (in shares)                 (2,000)        
Issuance of common shares in connection with private exchanges of Inseego convertible 5.5% senior notes 66,087   $ 14 66,073                  
Issuance of common shares in connection with the Notes Exchange (shares)     13,739,000                    
Exercise of warrants $ 1,861   $ 0 1,861                  
Exercise of warrants (shares) 338,454   338,000                    
Share-based compensation $ 5,981     5,981                  
Series E preferred stock dividends 0     1,227   (1,227)              
Ending balance at Jun. 30, 2020 (41,928) $ 0 $ 97 686,410 (15,783) (712,558) (94)            
Ending Balance (shares) at Jun. 30, 2020   35,000 97,018,000                    
Beginning balance at Mar. 31, 2020 27,803 $ 0 $ 96 682,047 (17,359) (636,893) (88)            
Beginning Balance (shares) at Mar. 31, 2020   37,000 96,180,000                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) (74,836)         (74,830) (6)            
Foreign currency translation adjustment 1,576       1,576                
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 1,663   $ 1 1,662                  
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)     838,000                    
Taxes withheld on net settled vesting of restricted stock units (208)     (208)                  
Repurchase of Series E preferred stock (in shares)                 (2,000)        
Repurchase of Series E preferred stock (2,354)     (2,354)                  
Share-based compensation 4,428     4,428                  
Series E preferred stock dividends 0     835   (835)              
Ending balance at Jun. 30, 2020 $ (41,928) $ 0 $ 97 $ 686,410 $ (15,783) $ (712,558) $ (94)            
Ending Balance (shares) at Jun. 30, 2020   35,000 97,018,000